Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)

Seminars in Arthritis and Rheumatism - Tập 58 - Trang 152149 - 2023
Namrata Singh1, Vithal Madhira2, Chen Hu3, Amy L. Olex4, Timothy Bergquist5, Kathryn C. Fitzgerald3, Jared D. Huling6, Rena C. Patel7, Jasvinder A. Singh8,9,10
1Division of Rheumatology, Department of Internal Medicine, University of Washington, Seattle, WA 98195, United States
2Palila Software, Reno, NV, United States
3Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
4Virginia Commonwealth University, Wright Center for Clinical and Translational Research, 203 E Cary St, Richmond, VA 23298, United States
5Sage Bionetworks, Seattle, WA 98109, United States
6Division of Biostatistics, University of Minnesota, Minneapolis, MN, United States
7Departments of Medicine and Global Health, University of Washington, Seattle, WA, 98104, United States
8Medicine Service, VA Medical Center, 700 19th St S, Birmingham, AL 35233 United States
9Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), 510 20th Street S, Birmingham, AL 35294-0022, United States
10Department of Epidemiology at the UAB School of Public Health, 1665 University Blvd., Ryals Public Health Building, Birmingham, AL 35294-0022, United States

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Seminars in Arthritis and Rheumatism

Tập 58

152149

Thông tin tác giả